$CTOR
Citius Oncology, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cranford, NJ
CTOR chart
What traders are saying about $CTOR
Latest postsCitius Oncology, Inc. news
- CTOR Stock Price, Quote & Chart
ChartMill ·
- Citius Oncology Reports LYMPHIR Unit Sales, Vial Orders for Q4 2026
The Clinical Trial Vanguard ·
- Citius Oncology Reports 120% Growth in Fourth-Quarter LYMPHIR Shipments
Quiver Quantitative ·
- With its sales team nationwide, Citius Oncology (CTOR) reports preliminary, unaudited shipment growth.
Stock Titan ·
- Citius Oncology LYMPHIR wholesaler units rise 120% in Q4 2026
StreetInsider ·
- Citius Oncology reports 120% jump in LYMPHIR wholesaler sales By Investing.com
Investing.com Nigeria ·
- Citius Oncology's LYMPHIR sales double in Q4 20...
Pluang ·
- Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026
Yahoo Finance ·
- Citius Oncology Gets Nasdaq Extension to Meet $1 Bid Price Requirement
TradingView ·
- Nasdaq gives Citius Oncology (NASDAQ: CTOR) more time to meet its $1 share-price rule.
Stock Titan ·
- Citius Oncology, Inc. Estimates – NASDAQ:CTOR
TradingView ·
- Citius Pharmaceuticals to Participate in October 2026 Investor Conferences
Yahoo Finance ·
Citius Oncology, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$24.8M | -$21.1M | $2.4M | $380,811 |
| Diluted EPS | $-0.34 | $-0.31 | $0.27 | $0.12 |
| Total assets (year end) | $110.0M | $90.5M | $72.6M | $68.2M |
| Cash and equivalents (year end) | $7.3M | – | – | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Citius Oncology, Inc.
- Ticker
- CTOR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cranford, NJ
- Incorporated in
- DE
- Fiscal year end
- September 30
- SEC CIK
- 1851484
- Former names
- TenX Keane Acquisition
Frequently asked questions
What exchange is Citius Oncology, Inc. listed on?
Citius Oncology, Inc. trades on the Nasdaq under the ticker symbol CTOR.
What industry is Citius Oncology, Inc. in?
Citius Oncology, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Citius Oncology, Inc. headquartered?
Citius Oncology, Inc.'s business address on file with the SEC is in Cranford, NJ.
When does Citius Oncology, Inc.'s fiscal year end?
Citius Oncology, Inc.'s fiscal year ends on September 30.